Augmentation by cytochalasin B of antigen receptor-mediated activation of normal and malignant human B lymphocytes.
Saltz
L
L
Laboratory of Immunology, Rockefeller University New York.
Knowles
D M
DM
Mechanic
S
S
Pasley
P
P
Brooks
R
R
Wakai
M
M
Chiorazzi
N
N
D000911:Antibodies, Monoclonal / Q000276:immunology; D000954:Antigens, Surface / Q000276:immunology; D001402:B-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D002469:Cell Separation; D002478:Cells, Cultured; D003571:Cytochalasin B / Q000494:pharmacology*; D006801:Humans; D007143:Immunoglobulin Heavy Chains / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects*; D009000:Monocytes / Q000276:immunology; D014066:Palatine Tonsil / Q000166:cytology; D010641:Phenotype; D011947:Receptors, Antigen, B-Cell / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology
D000911:Antibodies, Monoclonal; D000954:Antigens, Surface; D007143:Immunoglobulin Heavy Chains; D007075:Immunoglobulin M; D011947:Receptors, Antigen, B-Cell; D003571:Cytochalasin B